Jill Corre

机构：Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Inserm, Centre Hospitalier Universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse · ORCID：0000-0003-1580-6106

发表论文 588 篇 · 总被引 8416 次 · h-index 45

代表论文

• Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma (2026 · Nature Medicine · 被引 10)
• Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma (2025 · Journal of Clinical Oncology · 被引 10)
• FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial (2026 · Blood Advances · 被引 2)
• PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma (2026 · Blood · 被引 1)
• Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma (2026 · Biomarker Research)
• IFM 2026 Recommendations for First-Line Treatment of Newly Diagnosed Multiple Myeloma (2026 · Clinical Lymphoma Myeloma & Leukemia)